Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-28T05:56:46.560Z Has data issue: false hasContentIssue false

Chapter 17 - Fertility-Saving Surgery for Gynecological Cancers

from Section 5 - Fertility Preservation Strategies in the Female: Medical/Surgical

Published online by Cambridge University Press:  27 March 2021

Jacques Donnez
Affiliation:
Catholic University of Louvain, Brussels
S. Samuel Kim
Affiliation:
University of Kansas School of Medicine
Get access

Summary

Fertility preservation, especially in women of reproductive age undergoing gonadotoxic treatment, has become an important part of our practice. This is reflected in the increasing number of publications on the subject. A recent PubMed search yields 518 articles on fertility preservation published in the time period of 1980–2000 and 4,288 others between 2000 and 2017. Today, failure to discuss fertility preservation with young women scheduled to undergo radiotherapy or chemotherapy could be considered as malpractice.

Type
Chapter
Information
Fertility Preservation
Principles and Practice
, pp. 187 - 196
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ferlay, J, Soerjomataram, I, Dikshit, R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015;136(5):E359E386.Google Scholar
Howlader, N, Noone, AM, Krapcho, M et al. (eds.). SEER Cancer Statistics Review, 1975–2012. Bethesda, MD: National Cancer Institute, http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015.Google Scholar
Bentivegna, E, Gouy, S, Maulard, A et al. Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol, 2016;17:e240e253.Google Scholar
Wright, JD, NathavithArana, R, Lewin, SN et al. Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access. Obstet Gynecol, 2010;115:585590.Google Scholar
Hartman, CA, Teixeira, JC, Barbosa, SB et al. Analysis of conservative surgical treatment and prognosis of microinvasive squamous cell carcinoma of the cervix stage IA1: results of follow-up to 20 years. Int J Gynecol Cancer, 2017 February;27(2):357363.Google Scholar
Spoozak, L, Lewin, SN, Burke, WM et al. Microinvasive adenocarcinoma of the cervix. Am J Obstet Gynecol, 2012;206:80:e16.CrossRefGoogle ScholarPubMed
Cibula, D, Pötter, R, Planchamp, F et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Radiother Oncol, 2018 June;127(3):404416.CrossRefGoogle ScholarPubMed
Winter, WE 3rd, Kucera, PR, Rodgers, W et al. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol, 2002;100:671676.Google Scholar
Colombo, N, Carinelli, S, Colombo, A et al. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2012;23(Suppl 7):vii2732.Google Scholar
Baiocchi, G, de Brot, L, Faloppa, CC et al. Is parametrectomy always necessary in early-stage cervical cancer? Gynecol Oncol, 2017;146(1): 16–19.Google Scholar
Shim, SH, Lim, MC, Kim, HJ et al. Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation. PLoS One, 2018 January 31;13(1):e0189847.Google Scholar
Gien, LT, Covens, A. Fertility-sparing options for early stage cervical cancer. Gynecol Oncol, 2010;117:350357.Google Scholar
Dargent, D, Martin, X, Sacchetoni, A, Mathevet, P. Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer, 2000;88:18771882.Google Scholar
Xu, L, Sun, FQ, Wang, ZH. Radical trachelectomy versus radical hysterectomy for the treatment of early cervical cancer: a systematic review. Acta Obstet Gynecol Scand, 2011;90:12001209.Google Scholar
Zapardiel, I, Cruz, M, Diestro, MD, Requena, A, Garcia-Velasco, JA. Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers. Hum Reprod Update, 2016; 22(3):28–305.Google Scholar
Machida, H, Mandelbaum, RS, Mikami, M et al. Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer: trachelectomy versus hysterectomy. Am J Obstet Gynecol, 2018 August 20. pii: S00029378(18):30673–30672.Google Scholar
Helpman, L, Grisaru, D, Covens, A. Early adenocarcinoma of the cervix: is radical vaginal trachelectomy safe? Gynecol Oncol, 2011;123:9598.Google Scholar
Plante, M, Gregoire, J, Renaud, MC, Roy, M. The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol, 2011;121: 290297.Google Scholar
Hoogendam, JP, Zweemer, RP, Hobbelink, MG et al. 99mTc-Nanocolloid SPECT/MRI fusion for the selective assessment of nonenlarged sentinel lymph nodes in patients with early-stage cervical cancer. J Nucl Med, 2016 April;57(4):551556.Google Scholar
Lakhman, Y1, Akin, O, Park, KJ et al. Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. Radiology, 2013 October;269(1):149158.Google Scholar
Shepherd, JH, Spencer, C, Herod, J, Ind, TE. Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women. BJOG, 2006;113:719724.Google Scholar
Rob, L, Skapa, P, Robova, H. Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol, 2011;12: 192200.CrossRefGoogle ScholarPubMed
Delgado, G, Bundy, B, Zaino, R et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 1990;38:352357.Google Scholar
Plante, M, Lau, S, Brydon, L et al. Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report. Gynecol Oncol, 2006;101:367370.CrossRefGoogle ScholarPubMed
Robova, H, Halaska, MJ, Pluta, M et al. Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer. Gynecol Oncol, 2014;135:213216.CrossRefGoogle ScholarPubMed
Saso, S, Ghaem-Maghami, S, Chatterjee, J et al. Abdominal radical trachelectomy in West London. BJOG, 2012;119:187193.Google Scholar
Lintner, B, Saso, S, Tarnai, L et al. Use of abdominal radical trachelectomy to treat cervical cancer greater than 2 cm in diameter. Int J Gynecol Cancer, 2013;23:10651070.CrossRefGoogle ScholarPubMed
Salihi, R, Leunen, K, Van Limbergen, E et al. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer. Gynecol Oncol, 2015;139:447451.Google Scholar
Saadi, JM, Perrotta, M, Orti, R et al. Laparoscopic radical trachelectomy: technique, feasibility, and outcomes. JSLS, 2015;19:e2013.00248.Google Scholar
Pareja, R, Rendon, GJ, Vasquez, M et al. Immediate radical trachelectomy versus neoadjuvant chemotherapy followed by conservative surgery for patients with stage IB1 cervical cancer with tumors 2 cm or larger: A literature review and analysis of oncological and obstetrical outcomes. Gynecol Oncol, 2015;137:574580.Google Scholar
Bentivegna, E, Maulard, A, Pautier, P et al. Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature. Fertil Steril, 2016 October;106(5):11951211.Google Scholar
Kasuga, Y, Nishio, H, Miyakoshi, K et al. Pregnancy outcomes after abdominal radical trachelectomy for early-stage cervical cancer: a 13-year experience in a single tertiary-care center. Int J Gynecol Cancer, 2016;26:163168.Google Scholar
Li, X, Li, J, Wu, X. Incidence, risk factors and treatment of cervical stenosis after radical trachelectomy: a systematic review. Eur J Cancer, 2015;51:17511759.Google Scholar
Ghadjar, P, Budach, V, Kohler, C, Jantke, A, Marnitz, S. Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation. Radiat Oncol, 2015;10:50.Google Scholar
Donnez, J, Dolmans, MM. Fertility preservation in women. Nat Rev Endocrinol, 2013;9:735749.Google Scholar
Pareja, R, Rendon, GJ, Sanz-Lomana, CM, Monzon, O, Ramirez, PT. Surgical, oncological, and obstetrical outcomes after abdominal radical trachelectomy – a systematic literature review. Gynecol Oncol, 2013;131:7782.Google Scholar
Kasuga, Y, Miyakoshi, K, Nishio, H et al. Mid-trimester residual cervical length and the risk of preterm birth in pregnancies after abdominal radical trachelectomy: a retrospective analysis. BJOG, 2017 October;124(11):17291735.Google Scholar
Alvarez, RM, Biliatis, I, Rockall, A et al. MRI measurement of residual cervical length after radical trachelectomy for cervical cancer and the risk of adverse pregnancy outcomes: a blinded imaging analysis. BJOG. 2018 August 12. DOI:10.1111/1471-0528.15429. [Epub ahead of print].CrossRefGoogle Scholar
Mathevet, P, Laszlo de, Kaszon E, Dargent, D. Fertility preservation in early cervical cancer. Gynecol Obstet Fertil, 2003;31:706712.Google Scholar
Lintner, B, Saso, S, Tarnai, L et al. Use of abdominal radical trachelectomy to treat cervical cancer greater than 2 cm in diameter. Int J Gynecol Cancer, 2013;23:10651070.Google Scholar
Mangler, M, Lanowska, M, Bartens, A et al. Closure of the cervical os in patients after fertility preserving treatment for early cervical cancer – results of a prospective observational study. J Perinat Med, 2017 November 27;45(8):941945.CrossRefGoogle ScholarPubMed
Lee, TS, Jung, JY, Kim, JW et al. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol, 2007;104:5257.CrossRefGoogle ScholarPubMed
Renehan, AG, Tyson, M, Egger, M, Heller, RF, Zwahlen, M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 2008;371:569578.CrossRefGoogle Scholar
Navarria, I, Usel, M, Rapiti, E et al. Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment? Gynecol Oncol, 2009;114:448451.CrossRefGoogle ScholarPubMed
Amant, F, Moerman, P, Neven, P et al. Endometrial cancer. Lancet, 2005;366:491505.Google Scholar
Koh, WJ, Greer, BE, Abu-Rustum, NR et al. Uterine neoplasms, version 1.2014. J Natl Compr Canc Netw, 2014;12:248280.Google Scholar
Rodolakis, A, Biliatis, I, Morice, P et al. European Society of Gynecological Oncology Task Force for Fertility Preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients. Int J Gynecol Cancer, 2015;25:12581265.Google Scholar
Park, JY, Kim, DY, Kim, TJ et al. Hormonal therapy for women with stage IA endometrial cancer of all grades. Obstet Gynecol, 2013 July;122(1):714.Google Scholar
Yuk, JS, Song, JY, Lee, JH et al. Levonorgestrel-releasing intrauterine systems versus oral cyclic medroxyprogesterone acetate in endometrial hyperplasia therapy: a meta-analysis. Ann Surg Oncol, 2017;24:13221329.Google Scholar
Gunderson, CC, Fader, AN, Carson, KA et al. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol, 2012;125:477482.CrossRefGoogle ScholarPubMed
Ushijima, K, Yahata, H, Yoshikawa, H et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol, 2007;25:27982803.Google Scholar
Park, JY, Lee, SH, Seong, SJ et al. Progestin retreatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol, 2013;129:711.Google Scholar
Greenwald, ZR, Huang, LN, Wissing, MD et al. Does hormonal therapy for fertility preservation affect the survival of young women with early stage endometrial cancer? Cancer, 2017;123:15451554.Google Scholar
Park, JY, Seong, SJ, Kim, TJ et al. Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer. Gynecol Oncol, 2017 July;146(1):3943.Google Scholar
Alonso, S, Castellanos, T, Lapuente, F et al. Hysteroscopic surgery for conservative management in endometrial cancer: a review of the literature. Ecancermedicalscience, 2015;9:505.CrossRefGoogle ScholarPubMed
Jadoul, P, Donnez, J. Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma. Fertil Steril, 2003 December;80(6):13151324.Google Scholar
Chiva, L, Lapuente, F, Gonzalez-Cortijo, L et al. Sparing fertility in young patients with endometrial cancer. Gynecol Oncol, 2008;111(Suppl):S101S104.Google Scholar
Gonthier, C, Walker, F, Luton, D et al. Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer. Gynecol Oncol, 2014;133:3337.Google Scholar
Rodolakis, A, Biliatis, I, Morice, P et al. European Society of Gynecological Oncology Task Force for Fertility Preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients. Int J Gynecol Cancer, 2015;25:12581265.Google Scholar
Juretzka, MM, O’ Hanlan, KA, Katz, SL, El-Danasouri, I, Westphal, LM. Embryo cryopreservation after diagnosis of stage IIB endometrial cancer and subsequent pregnancy in a gestational carrier. Fertil Steril, 2005;83:1041.Google Scholar
Martınez, F, Devesa, M, Coroleu, B et al. Cancer and fertility preservation: Barcelona consensus meeting. Gynecol Endocrinol, 2013 April;29(4):285291.Google Scholar
Siegel, RL, Miller, KD, Jemal, A. Cancer statistics, 2016. CA Cancer J Clin, 2016;66:730.Google Scholar
Skirnisdottir, I, Garmo, H, Wilander, E, Holmberg, L. Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer, 2008;123:18971901.Google Scholar
Zanetta, G, Rota, S, Chiari, S et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol, 2001;19:26582664.Google Scholar
du Bois, A, Ewald-Riegler, N, de Gregorio, N et al.; Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) study group borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) study group. Eur J Cancer, 2013 May;49(8):19051914.Google Scholar
Morice, P, Camatte, S, El Hassan, J et al. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril, 2001 January;75(1):9296.CrossRefGoogle ScholarPubMed
Donnez, J, Munschke, A, Berliere, M et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril, 2003 May;79(5):12161221.Google Scholar
Zanetta, G, Rota, S, Lissoni, A et al. Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors. Gynecol Oncol, 2001 April;81(1):6366.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Management of adnexal masses. Obstet Gynecol, 2007;110:201214.CrossRefGoogle Scholar
du Bois, A, Trillsch, F, Mahner, S, Heitz, F, Harter, P. Management of borderline ovarian tumors. Ann Oncol, 2016 April;27(Suppl 1):i20i22.Google Scholar
Vasconcelos, I, de Sousa, Mendes M. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk. Eur J Cancer, 2015 March;51(5):620631.Google Scholar
Fauvet, R, Boccara, J, Dufournet, C et al. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer, 2004;100:11451151.Google Scholar
Suh-Burgmann, E. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol, 2006;103:841847.Google Scholar
Helpman, L, Beiner, ME, Aviel-Ronen, S et al. Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors. Fertil Steril, 2015 July;104(1):138–44.CrossRefGoogle ScholarPubMed
Uzan, C, Muller, E, Kane, A et al. Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary. Ann Oncol, 2014;25:166171.Google Scholar
Vasconcelos, I, Darb-Esfahani, S, Sehouli, J. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates. BJOG, 2016;123:498508.Google Scholar
Nam, JH. Borderline ovarian tumors and fertility. Curr Opin Obstet Gynecol, 2010 June;22(3):227234.CrossRefGoogle ScholarPubMed
Daraï, E, Fauvet, R, Uzan, C et al. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update, 2013 March–April;19(2):151166.Google Scholar
Denschlag, D, von Wolff, M, Amant, F et al. Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery. Gynecol Obstet Invest, 2010;70(3):160165.Google Scholar
Morice, P, Denschlag, D, Rodolakis, A et al.; Fertility Task Force of the European Society of Gynecologic Oncology.Recommendations of the fertility task force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors. Int J Gynecol Cancer, 2011 July;21(5):951963.Google Scholar
Redman, C, Duffy, S, Bromham, N, Francis, K. Guideline Development Recognition and initial management of ovarian cancer: summary of NICE guidance. BMJ, 2011;342:d2073.Google Scholar
Bentivegna, E, Fruscio, R, Roussin, S et al. Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients. Fertil Steril, 2015 November;104(5):13191324.Google Scholar
Ghezzi, F, Cromi, A, Fanfani, F et al. Laparoscopic fertility-sparing surgery for early ovarian epithelial cancer: A multi-institutional experience. Gynecol Oncol, 2016 June;141(3):461465.Google Scholar
Zapardiel, I, Cruz, M, Diestro, MD, Requena, A, Garcia-Velasco, JA. Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers. Hum Reprod Update, 2016 April;22(3):281305.Google Scholar
Smith, HO, Berwick, M, Verschraegen, CF et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol, 2006 May;107(5):10751085.Google Scholar
Park JY, Kim DY, Suh DS et al. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors. Gynecol Oncol. 2017 Jun;145(3):513–518Google Scholar
Jorge, S, Jones, NL, Chen, L et al. Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998–2012. Gynecol Oncol, 2016 August;142(2):261266.Google Scholar
Kang, H, Kim, TJ, Kim, WY et al. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Gynecol Oncol, 2008;111:106110.Google Scholar
Mangili, G, Sigismondi, C, Lorusso, D et al. Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience. Gynecol Oncol, 2011;121:280284.Google Scholar
Reed, N, Millan, D, Verheijen, R, Castiglione, M; ESMO Guidelines Working Group. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2010 May;21(Suppl 5):v31-6.Google Scholar
Cushing, B, Giller, R, Cullen, JW et al.; Pediatric Oncology Group 9049; Children’s Cancer Group 8882. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study–Pediatric Oncology Group 9049 and Children’s Cancer Group 8882. J Clin Oncol, 2004 July 1;22(13):26912700.Google Scholar
Billmire, DF, Cullen, JW, Rescorla, FJ et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children’s Oncology Group. J Clin Oncol, 2014;32:465470.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×